Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 4/20 | 0.39 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.39 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.39 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.38 |
| ▸ | MAOB | P27338 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29828705 | 1.00 | IDO1 (0.40) | IDO1ALDH1A1CYP3A4CYP1A2MAOA | |
| SCHEMBL26187073 | 0.80 | PTPN1 (0.38) | IDO1ALDH1A1MAOATXNRD1TXNRD3 | |
| SCHEMBL27379681 | 0.79 | TSHR (0.38) | ALDH1A1CYP3A4CYP1A2MAPTTDP1 | |
| SCHEMBL6824008 | 0.78 | CA1 (0.42) | IDO1ALDH1A1CYP3A4CYP1A2MAOA | |
| SCHEMBL9155082 | 0.76 | ALDH1A1 (0.57) | ALDH1A1CYP3A4CYP1A2MAPTHSD17B10 | |
| SCHEMBL23655043 | 0.75 | ALDH1A1 (0.48) | IDO1ALDH1A1MAPTHSD17B10TDP1 | |
| SCHEMBL2863441 | 0.75 | L3MBTL1 (0.42) | ALDH1A1CYP3A4CYP1A2MAPTHSD17B10 | |
| SCHEMBL30645929 | 0.75 | MEN1 (0.42) | ALDH1A1CYP3A4CYP1A2MAOAMAPT | |
| SCHEMBL15762161 | 0.75 | MEN1 (0.42) | ALDH1A1CYP3A4CYP1A2MAOAMAPT | |
| SCHEMBL4371605 | 0.75 | ALDH1A1 (0.37) | ALDH1A1CYP3A4CYP1A2HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7188219-A | — | — | None | — | — | JP | disclosed |
| US-20260116891-A1 | Oxazepin Derivative | TEIJIN PHARMA LTD (JP) | 2026-04-30 | — | — | US | disclosed |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260034123-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12492180-B2 | Process and intermediates for the preparation of Voxelotor | CURIA SPAIN, S.A.U. (ES) | 2025-12-09 | — | — | US | disclosed |
| US-20250268979-A1 | COMBINATION OF MACROCYCLIC CFTR MODULATORS WITH CFTR CORRECTORS AND / OR CFTR POTENTIATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-08-28 | — | — | US | disclosed |
| EP-4587012-A1 | COMBINATION OF MACROCYCLIC CFTR MODULATORS WITH CFTR CORRECTORS AND / OR CFTR POTENTIATORS | Idorsia Pharmaceuticals Ltd (CH) | 2025-07-23 | — | — | EP | disclosed |
| EP-4562016-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| EP-4512811-A1 | OXAZEPINE DERIVATIVE | Teijin Pharma Limited (JP) | 2025-02-26 | — | — | EP | disclosed |
| US-20250002497-A1 | IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION | BRISTOL MYERS SQUIBB CO (US) | 2025-01-02 | — | — | US | disclosed |
| EP-0652216-B1 | Substituted Pyridyl salicylic aldehyde and salicylic acid derivatives, methods for preparing them and their use as herbicides | BASF AG (DE) | 2001-02-28 | — | — | EP | disclosed |
| EP-0657441-B1 | Cyclic acetals, processes for their production and conversion into herbicides | BASF AG (DE) | 2000-03-01 | — | — | EP | disclosed |
| US-5783521-A | Substituted pyridylsalicylaldehyde or -salicylic acid derivatives, their preparation and their use as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-21 | — | — | US | disclosed |
| US-5777118-A | PLANT SAFENING AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-07 | — | — | US | disclosed |
| US-5627136-A | HERBICIDES, ANTIGROWTH REGULATORS AND PLANT GROWTH REGULATORS | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-06 | — | — | US | disclosed |
| US-5569640-A | HERBICIDE | BASF AKTIENGESELLSCHAFT (DE) | 1996-10-29 | — | — | US | disclosed |
| JP-H07188219-A | CYCLIC ACETAL AND PREPARATION THEREOF | BASF AG | 1995-07-25 | — | — | JP | disclosed |
| EP-0657441-A2 | Cyclic acetals, processes for their production and conversion into herbicides | BASF Aktiengesellschaft (DE) | 1995-06-14 | — | — | EP | disclosed |
| EP-0656357-A1 | Substituted pyridyl-n-oxide salicylic aldehyde and salicylic acid derivatives, methods for preparing them and their use as herbicides | BASF Aktiengesellschaft (DE) | 1995-06-07 | — | — | EP | disclosed |
| EP-0652216-A2 | Substituted Pyridyl salicylic aldehyde and salicylic acid derivatives, methods for preparing them and their use as herbicides | BASF Aktiengesellschaft (DE) | 1995-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034123-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CDK2, CDK1, CDK20 | IDO1 2935/4885ALDH1A1 4103/4885CYP3A4 2675/4885 |
| US-20250268979-A1 | COMBINATION OF MACROCYCLIC CFTR MODULATORS WITH CFTR CORRECTORS AND / OR CFTR POTENTIATORS | CFTR, RRS1, PKD1 | IDO1 4540/4885ALDH1A1 2971/4885CYP3A4 1774/4885 |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | HBZ, HBB, HBG2 | IDO1 2695/4885ALDH1A1 1843/4885CYP3A4 88/4885 |
| US-20250002497-A1 | IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION | F2RL3, F2R, TMPRSS4 | IDO1 1874/4885ALDH1A1 2524/4885CYP3A4 20/4885 |
| US-12492180-B2 | Process and intermediates for the preparation of Voxelotor | VPS51, KIF15, VAT1 | IDO1 1485/4885ALDH1A1 1171/4885CYP3A4 1138/4885 |
| US-20260116891-A1 | Oxazepin Derivative | HCRTR2, HCRTR1, OXTR | IDO1 845/4885ALDH1A1 754/4885CYP3A4 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.